Therapeutic Treatment of Acute Inflammatory Demyelinating Polyneuropathy: Single Case Report

Abstract

Background: Guillain-Barré syndrome is an acute inflammatory demyelinating poly-radiculoneuropathy (AIDP) characterized by weakness and a reflexia, typically. The cause of AIDP is still unknown, with suspicions of viral or bacterial infection preceding diagnosis. It can affect people of all ages, gender, or ethnic background, with equal incidence rate in both men and women. The incidence rate for AIDP is rare, affecting 1–2 people in 100,000 annually. Acute Inflammatory Demyelinating Poly-radiculoneuropathy is the most common subtype of Guillain-Barré syndrome. The Result of the case report which shows that at the time of admission, the level of intensity of pain, ADL and balance which measured through NPRS—Pre: 10.5 (P<0.5) and Post: 13 (P<0.5); MBI—Pre: 84(P<0.5) and Post: 100(P<0.5) and BBS—Pre: 32 (P<0.5) and Post: 56 (P<0.5).The investigator Concluded that the present study case report, the opportunity to document outcome of the physiotherapy intervention for AIDP during this episode. Patient with AIDP at the time of discharge achieved all functional capacity of physiotherapy goals and able to return of period functional status, and restore mobility, only mild sensory deficit and minimal weakness. Therefore, the use of functionally based intervention outcome measured during PT (Physical Therapy) management of this strategy for the therapeutic management of AIDP who proved to be clinically more beneficial.

Keywords: Acute Inflammatory Demyelinating Polyneuropathy, (MBI)Modified Barthel Index, (NPRS)Numeric Pain Rating Scale and (BBS)Berg Balance Scale

Cite this Article

Karthikeyan Thangavelu. Therapeutic Treatment of Acute Inflammatory Demyelinating Polyneuropathy: Single Case Report. Research & Reviews A Journal of Neuroscience; 9(1): 13–18p.